Quality of Care

What Do Other Experts Say About You?

National Cancer Institute designation

Vanderbilt-Ingram has been one of a select few National Cancer Institute-designated cancer centers since 1995 and one of only 41 achieving the NCI’s highest distinction, as a Comprehensive Cancer Center (CCC), since 2001.

To achieve designation as Comprehensive Cancer Center, a rigorous evaluation must find the center to be among the nation’s leaders in all types of cancer research, treatment, prevention, and outreach/education. They must demonstrate strength, depth, innovation and commitment in these areas:

  • Basic research in the laboratory
  • Translational research that takes discoveries from the lab to clinical care
  • Clinical research including patient studies called clinical trials
  • Cancer prevention research and programs
  • Cancer information services
  • Community education and outreach
  • Training of the next generation of physicians, researchers, nurses and other cancer professionals

In addition, the NCI’s Cancer Advisory Board, appointed by the President of the United States, must recommend approval for comprehensive designation. Centers must report their progress and activities every year, and are thoroughly re-evaluated every three to five years to ensure that these strict standards continue to be met.

National Comprehensive Cancer Network

The Vanderbilt-Ingram Cancer Center was recently invited to join the prestigious National Comprehensive Cancer Network (NCCN), a non-profit alliance of 21 of the world’s leading cancer centers that have joined together to improve the quality of care for cancer patients everywhere.

Blue Distinction Center for Complex and Rare Cancers

Blue Cross Blue Shield Association, in collaboration with Blue Cross Blue Shield of Tennessee, has named Vanderbilt-Ingram Cancer Center a Blue Distinction Center for complex and rare cancers.

Types of rare or complex cancers covered by this designation and treated at Vanderbilt-Ingram include esophageal, pancreatic, liver, rectal, gastric, brain, bladder, thyroid, head and neck, soft tissue sarcoma, ocular melanoma, bone tumors and acute leukemia. Learn more....

Note: Designation as Blue Distinction Centers means that these facilities' overall experience and aggregate data met objective criteria established in collaboration with expert clinicians' and leading medical societies' recommendations. Individual outcomes may vary. To find out which services are covered under your policy at these or other facilities, please call your local Blue Cross and/or Blue Shield company ("Blue Plan").

Other distinctions and accreditations

Vanderbilt-Ingram Cancer Center and Vanderbilt Medical Center hold a number of other distinctions, accreditations and affiliations that relate to the depth, breadth and quality of our expertise in cancer treatment, research, prevention and education.

  • Joint Commission on Accreditation of Healthcare Organization
  • American College of Surgeons Commission on Cancer
  • American Nurses Credentialing Center Magnet Recognition Program
  • National Marrow Donor Program affiliate
  • American Association of Cancer Institutes
  • Foundation for the Accreditation of Cellular Therapy (blood and bone marrow transplant program)
  • Clinical Laboratory Improvement Amendment (blood and bone marrow transplant program)
  • NCI program for Phase I and Phase II clinical trials
  • Three NCI Specialized Programs of Research Excellence (lung, colon and breast cancer)
  • Association for the Accreditation of Human Research Protection Programs

You do not have JavaScript enabled. This site works better with JavaScript turned on.